Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Rlign algorithm for enhanced electrocardiogram analysis through heart rate-corrected ECG alignment for explainable classification and clustering.

European heart journal. Digital health·2026
Same author

Implementation and User Evaluation of an On-Premise Large Language Model in a German University Hospital Setting: Cross-Sectional Survey.

JMIR AI·2026
Same author

Response to 'promising advances and remaining challenges in AI-driven QTc estimation' by Zekai Yu.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

End-to-End Platform for Electrocardiogram Analysis and Model Fine-Tuning: Development and Validation Study.

Journal of medical Internet research·2026
Same author

Advancements in Renal Imaging: A Comprehensive Systematic Review of PET Probes for Enhanced GFR and Renal Perfusion Assessment.

Diagnostics (Basel, Switzerland)·2025
Same author

QTcNet: a deep learning model for direct heart rate corrected QT interval estimation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

378

Integrating 68Ga-PSMA-11 PET/CT with Clinical Risk Factors for Enhanced Prostate Cancer Progression Prediction.

Joanna M Wybranska1, Lorenz Pieper1, Christian Wybranski1

  • 1Division of Nuclear Medicine, Department of Radiology & Nuclear Medicine, Faculty of Medicine, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.

Cancers
|July 29, 2025
PubMed
Summary
This summary is machine-generated.

Combining Gallium-68 PSMA-11 PET/CT imaging biomarkers with clinical factors significantly improves prediction of early recurrence in high-risk prostate cancer (PCa) patients. Machine learning models enhance risk stratification for personalized treatment strategies.

Keywords:
68Ga-PSMA-11 PET/CTCAPRA scoreSUVmaxearly biochemical recurrenceoutcome predictionprostate cancer

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.7K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Related Experiment Videos

Last Updated: Sep 13, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

378
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.7K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Machine Learning in Medicine

Background:

  • High-risk prostate cancer (PCa) requires accurate prediction of early biochemical recurrence (eBCR) or clinical progression post-treatment.
  • Current risk stratification tools may benefit from integration of advanced imaging biomarkers.
  • 68Ga-PSMA-11 PET/CT offers detailed imaging of prostate cancer spread.

Purpose of the Study:

  • To evaluate if combining 68Ga-PSMA-11 PET/CT imaging biomarkers with clinical risk factors improves prediction of eBCR or clinical progression in high-risk PCa.
  • To develop and compare machine learning (ML) models for enhanced predictive accuracy.
  • To assess the utility of these models in guiding personalized treatment decisions.

Main Methods:

  • Analysis of data from 93 high-risk PCa patients who underwent 68Ga-PSMA-11 PET/CT and primary treatment.
  • Development of two predictive models: logistic regression (LR) and a probabilistic graphical model (PGM) based on a naïve Bayes framework.
  • Input variables selected based on statistical analysis, domain expertise, literature review, and expert input; comparison against CAPRA risk score.

Main Results:

  • Key predictors identified: binarized CAPRA score, maximal intraprostatic PSMA uptake (SUVmax), bone metastases, nodal involvement, and seminal vesicle infiltration.
  • The PGM demonstrated superior performance (balanced accuracy: 0.73) compared to LR (0.50) and CAPRA score (0.59).
  • A decision tree derived from the PGM provided an explainable classifier, prioritizing CAPRA score, SUVmax, and PET-detected tumor sites.

Conclusions:

  • Integration of 68Ga-PSMA-11 imaging biomarkers with clinical parameters significantly enhances prediction models for high-risk PCa progression.
  • The PGM offers superior balanced accuracy and effective risk stratification.
  • These findings support the use of advanced imaging and ML for personalized treatment strategies in PCa.